基蛋生物科技股份有限公司股东减持股份结果公告

Summary of Key Points Core Viewpoint - Nanjing Aiji Business Information Consulting Co., Ltd. has completed its share reduction plan for G-Bio Technology Co., Ltd., reducing its holdings by 666,600 shares, which is 0.1314% of the total share capital [1][5]. Shareholder Holding Situation - Nanjing Aiji holds 16,881,219 shares of G-Bio, representing 3.33% of the total share capital, acquired through pre-IPO holdings and capital reserve conversion [1]. Implementation of Reduction Plan - The reduction plan was fully executed, with a slight difference of 25 shares from the planned reduction due to unexecuted fractional shares [5]. - Key executives, including the vice general managers and financial director, reduced their holdings through Nanjing Aiji, with specific reductions detailed for each [5]. Major Shareholder and Executive Actions - The controlling shareholder, Su Enben, did not reduce his indirect holdings during this share reduction process [2][5]. - The actual reduction matched the previously disclosed plan, confirming that the plan was executed as intended [6].